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ABSTRACT: The application of modern biotechnology to plant breeding is considered to 
be more efficient and quicker than conventional breeding techniques in the development of 
new and more resilient crop varieties. To test the impact that biotechnology is having on a 
industrial plant breeding activities, we relate firm level Plant Variety Protection Certificate 
(PVPC) applications to corresponding expenditure on research and development (R&D), 
agricultural biotechnology patents applications, field trials of genetically modified crops, 
firm structure, as well as industry specific characteristics. Regression results indicate 




Prior to the twentieth century, most increases in agricultural production were due to 
increases in land devoted to crop production. As cities and industries took more land, the amount 
of open, farmable land became increasingly scarce. Farmers realized the importance of crop 
management and selection practices. For example, crops could be rotated to replace nutrients in 
the soil and selected for favorable traits given their environment, such as drought tolerance, 
resistance to pests, and higher yields.. However, as populations continue to expand, it has 
became increasingly important to push the threshold of crop production, i.e. to increase 
production yields.  
Attaining greater yields requires selecting, developing and growing the most productive 
and durable crop varieties. At first, science contributed tools like the principles of Mendelian 
inheritance for trait selection and cross breeding. Such “conventional” breeding methods have 
led to significant increases in yield potential of crops, but they are limited by intra-special mating 
and the time it takes hybrid varieties to grow and exhibit the desired trait. With evidence now 
emerging that yield gains of major cereals is slowing down, conventional breeding may not be 
able to deliver the genetic gains required to achieve higher yields and meet rising food demand 
(Pingali and Heisey, 1999) 
  2In this regard, advances in molecular biology, structural and functional genomics, 
bioinformatics and related fields have led to the development of biotechnology driven 
tools, methods, and products that promise to increase the productivity of plant breeding 
research towards increasing farming productivity. Biotechnology is a shortcut; 
biotechnological methods, such as genetic recombination and Marker Aided Selection 
(MAS), possess a number of advantages over conventional breeding techniques.   
  Using biotechnological techniques, genetic material can be manipulated or altered 
in such a way as to induce an organism (crop plant) to exhibit the desired phenotype by 
either introducing foreign DNA encoding a desired trait to the organism (recombination) 
or by changing or manipulating the genetic signals or material within the organism. The 
genetic element that corresponds to a given trait is the genotype; thus, scientists are now 
capable of physically introducing desired genotypes into a crop line without mating. In 
this way, genetic recombination speeds up the process. Furthermore, scientists are able to 
draw traits from a larger pool of genotypes because intra-species mating will no longer be 
a limitation as in conventional cross breeding. By allowing scientists to directly introduce 
genes corresponding to desired traits as opposed to conventional crossbreeding practices, 
recombinant techniques will cut costs and time in the creation of new and desirable 
varieties.  
Another use of biotechnology is Marker Aided Selection (MAS). Once a trait has 
been linked to a genotype(s), crop lines (wild type and GMO) can be selected for desired 
traits without having to actually grow them and look for the expression of a desired trait; 
scientists can just score the genotypes using molecular diagnostic tools. Using MAS, 
science can assist farmers in selecting a crop variety for their given needs prior to even 
  3growing the selected variety. (Drehr et al, 2000) identify a number of applications where 
marker aided selection techniques offer considerable cost savings compared to 
conventional selection methods. Most of these cost savings are due to the fact that with 
conventional breeding the breeder has to rely on observable differences of the underlying 
genetic characteristics within their product, which is both time consuming and since the 
advent of molecular diagnostic screens, inefficient. Biotechnology-based tools allow the 
breeder to identify desired genes of interest quickly, reliably and efficiently. As a direct 
consequence of these cost savings one would expect that a firm’s propensity to innovate 
would increase, ceteris paribus. Further, given that biotechnology tools shorten the time 
needed to develop new varieties vis-à-vis conventional breeding methods, one would also 
expect that new varieties will be developed and introduced at a much quicker pace than 
before. However, it is likely that the costs and benefits of biotechnology-based breeding 
programs are a function of the breeding objectives of the researcher, the organizational 
structure and research capacity of the breeder, and other site and environmental specific 
characteristics.  
  In this paper we examine and document the impacts of agricultural biotechnology 
on the productivity of overall plant breeding. We hypothesize that a firm’s investment in 
the development of biotechnology tools and techniques specific to plant breeding 
research, (1) is a ‘lumpy’ investment, but will (2) lower the marginal costs of conducting 
research; and (3) lead to more plant variety innovations (i.e. more PVPCs). We expect 
firms engaged in large amounts of plant biotechnology research activities (as proxied by 
agbiotech patents and number of field trials) to also have higher levels of plant breeding 
  4activities. A failure to find such a relationship would suggest that plant biotechnology 
has, as yet, not played a significant role in a firm’s breeding program.  
  The balance of the paper proceeds as follows. In Section II we examine the 
methods of previous attempts to characterize the relationship between research inputs and 
outputs. In Section III we specify the reduced form-econometric model, the data and 
estimation procedures to be used. The regression results are presented in Section V, 
followed by some concluding remarks in Section VI. 
 
II. Literature Review  
  There exists a significant body of research describing (or attempting to describe) 
the factors leading to innovation at the firm level. Specifically, the focus of much 
previous work has been to examine the relationship between research inputs and outputs, 
where patents are often used as a measure of research output (or innovation) and R&D 
expenditure used as measure of research input (e.g.  Griliches; Hausman et al, 1984; 
Crepon and Duguet, 1997). Griliches et al, examining firm-level cross sectional data, 
finds a strong relationship between the number of patents granted and R&D expenditures, 
leading him to conclude that patents are a good indicator of differences of inventive 
activity. While the patent-R&D relationship is weaker when differences within firms and 
across time are examined, the relationship remains statistically significant (Griliches et al, 
1990). 
  While a perfect proxy measure of technical change and competitive position, 
innovation, is yet to be found; patent statistics have proven adequate to that end. 
Unfortunately, patents as an innovation measure in the plant breeding industry may not 
  5appropriate for the simple reason that few new varieties are patented (or patentable)—
notwithstanding the surge of variety patents that have been awarded to a few firms in 
recent years.
1 Rather Plant Variety Protection Certificates (PVPC) awarded to firms are a 
more appropriate measure of outputs of the research process in plant breeding. Enacted in 
the Plant Variety Protection Act of 1970 (amended in 1994), a PVPC is a legal award of 
intellectual property rights over a new, distinct, uniform, and genetically stable variety of 
plant for a period of 20 years. PVPCs are administered by the U.S. Department of 
Agriculture. Like patents, PVPCs grant a developer intellectual property rights over a 
new “invention,” in this case a new, non-hybrid plant variety. However, unlike patents, 
PVPCs are static in their measure. They represent only the creation of a new, non-hybrid 
plant variety while a patent can represent any number of things. Also, unlike patents, 
R&D, and other inputs, PVPCs are relatively new (created in 1970) and unlikely to have 
contributed as much as an input to the process of innovation and therefore would not be 
viewed as an input. Moreover, PVPC are generally regarded as a weaker form of patent 
protection as the Plant Variety Protection Act allows farmers to save and replant 
proprietary seeds, and breeders to use the protected seeds in their research program 
without compensating the original breeder. 
  To our knowledge, no study has employed PVPC as an innovation measure to 
explore the research input-output relationship as it pertains to innovation in plant 
breeding. Rather the focus in this context has been to ask whether PVPCs are a useful 
mechanism to protect the innovator’s property rights that would result in higher R&D 
expenditure. The evidence on this issue is mixed.  Alston and Venner (2002) report that 
                                                 
1 The patenting of plant varieties is a controversial and unresolved issue. For a discussion see Janis and 
Kesan. 
  6for the U.S. the PVPA may have stimulated public (but not private-sector) investment in 
wheat varietal improvement. For Spain, however, Diez (2002) reports that the enactment 
of plant variety rights has had a positive incentive especially for the private sector. 
Kloppenburg argues that the increase in private breeding in the U.S. since the 1970 
represents an extension of pre-existing technology, and not necessarily that the passage of 
PVPA has caused an increase in breeding activities. The lack of clear evidence to support 
the claim that PVPC have an impact on excludability or appropriability has led some to 
suggest that PVPC are simply a “marketing tool” (Janis and Kesan) 
  Regardless of whether the PVPCs are an effective tool to protect the property 
rights of the plant breeder, they represent the culmination of the plant breeding process. 
Given that PVPA imposes four substantive protectability requirements—that it be new, 
distinct, uniform and stable—each PVPC is an innovation that requires some level of 
research effort. As such, they can be used in estimating a knowledge production function 
in which the outputs of plant breeding research are primarily a function of research 
expenditure (current and lagged) and the state of technology. We shall use the knowledge 
production function approach to test the hypothesis that a firm’s research activities in 
biotechnology has a spillover effect on its breeding program as argued in the 
introduction.  
 
III. Econometric Model 
We test our hypotheses using firm level panel data in the context of the 
productivity of plant breeding programs. We specify a plant breeding (knowledge) 
  7production function that relates the dependent variable (PVP applications) to other firm 
and industry specific variables as follows: 
 
   (1) 
, it V = f (Fi,t, Si, It ) 
where V  is the number of PVP certificate applications for firm i at time t.  F , it i,t is a 
vector of firm specific characteristics (such as R&D expenditure, AgBiotech patent 
applications, number of GM crop field trials), i is a firm index and t is a time index. S is a 
variable specific to research focus. I is a vector of environmental specific characteristics 
(firm invariant), such as institutional changes over time (for example, changes in the PVP 
Act). 
  The non-negative, integer nature of the dependant variable (PVP application 
counts) implies that the basic assumptions of OLS and linear panel data models, such as 
normality of the residuals are no longer satisfied, and appropriate count data models have 
to be employed (Srininvasan and Shankar). The most widely used of these is the Poisson 
regression model which imposes the restriction that mean and variance of the distribution 
are equal. However, studies of patent and R&D data have typically found the variance to 
exceed the mean of the distribution (e.g., Graff, Rausser and Small). Accordingly, to 
account for this over dispersion we shall use the Negative Binomial regression model to 
estimate the functional relationship between the number of novel plant varieties and the 
explanatory variables mentioned earlier.  
 
IV. Data and Estimation 
  8For this analysis we have pooled firm-specific data from 13 firms
2 involved in 
plant breeding over the period 1985 to 2001. The analysis includes total plant variety 
certificates applications from the indicated firms for the given years, the number of 
genetically modified organism field trials conducted by each firm, the number of 
agbiotech patent applications from each firm, total R&D expenditure for each firm, a 
dummy variable for firms with a multi-industry focus (for example, a firm conducting 
agbiotech research, chemical research, and pharmaceutical research). A dummy variable 
was also included to control for legislative change in the PVP Act (i.e. the 1994 
amendment to the Act). The PVP application and field trial data were obtained from on-
line databases, http://www.ars-grin.gov/cgi-bin/npgs/html/pvplist.pl and 
http://www.nbiap.vt.edu/ , respectively. The ag-biotech patent data used in this study is 
from Bennet et al (2002) who screened all patents filed with the U.S. patent office 
between August 1, 1982 and August 1, 2001 to search for ag-biotech patents. The 
screening process they used is based on queries using both international patent 
classification (IPC) codes and technology-related fields. A total of 4,313 patents were 
identified as being ag-biotech, but only those assigned to the firms of interest in this study 
are included. The R&D and sales figures for the publicly traded firms in our study comes 
from compustat, whereas for the two private firms (Asgrow and Holden’s) are author’s 
estimates based on publicly available news reports.  
A perennial problem in using Compustat data to acquire R&D expenditure is that 
the data is not broken down by line of business. While this is not an issue for firms fully 
vested in the just one industry (i.e. the seed and ag-biotech industry in this case), it 
                                                 
2 Asgrow, Calgene, DeKalb, Delta & Pineland, Holden’s, Lubrizol, Novartis, Pioneer, Seminis, Monsanto, 
DuPont, Mycogen, Dow 
  9becomes problematic for large diversified firms that have interests and investments in 
several industries and sub-industries (i.e. Dow, Monsanto, Novartis, DuPont). Therefore, 
to attain a measure of firm involvement in agbiotech R&D for firms with multi-industry 
focus, we applied a ratio of those firm’s Agbiotech patent applications in a given year to 
its total patent applications over that same year (we assume that the firm’s ratio of 
agbiotech patents to total patents represents the proportion that a firm is vested in biotech 
research) to that firm’s R&D expenditures. Total patent count was obtained from U.S. 
Patent and Trademark Office’s online database.  
R&D was found to be highly correlated with Agbiotech patent applications, 
suggesting that agbiotech patents are just as good, if not better, predictor of a firm’s PVP 
counts. This is in line with prior literature, which has tended to find that patents can be 
used to quantify the rate of innovation as either an input to the process or as an output. 
Comanor et al found (after adjusting for company size) significant correlation between 
patent applications and sales of new products (the output measure) but greater correlation 
between patent applications and total research employees (the input measure, leading 
them to conclude that patents may be a better index of research input than output.  
The use of patents as an input makes sense. Patents are intrinsically tied to 
appropriability and market availability. In an open market, one “might expect competitive 
forces to stimulate innovation and intellectual property protection to induce even more of 
it” (Gould et al, 1996). In effect, protection of intellectual property stimulates innovation; 
therefore, patents might be a better input than output variable. 
 
 
  10V. Results 
Standard Poisson regressions were applied to combinations of the explanatory 
variables - agbiotech patent applications, deflated R&D expenditures, field trials, 
company focus, legislation - and the dependent variable – PVP applications. It was 
quickly apparent that whenever the patents and R&D variables are included in the same 
equation one or the other is insignificant; however, individually both are significant. 
Perhaps this is because R&D expenditure is to be considered an input to the research 
stream that generates patents and therefore part of the same process flow. Furthermore, 
empirical evidence from previous studies has indicated a direct and contemporaneous 
relationship between R&D and patents. Indeed a Pearson Correlation Coefficient Matrix 
between R&D expenditures and agbiotech patent applications demonstrates a high degree 
of correlation, 0.74306, at the 99% confidence level (N=170). See Table I for regression 
results.
Table I. Regression Results            












































N  147 166 148 
(Standard Error) 
*Significant at the 90% level of confidence 
**Significant at the 95% level of confidence 
***Significant at the 99% level of confidence 
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  Table I, comparison of equation A with equations B and C clearly shows no relationship 
between PVPs and both agbiotech patent applications and R&D expenditures when both terms 
are included, but high levels of statistical significance when each term is included separately. 
Equations B and C show that both agbiotech patent applications and R&D expenditures are 
positively linked to PVP applications; as R&D expenditures and patents represent inputs to the 
innovation stream in the form of investment and acquired knowledge, this is to be expected. 
Further analysis of equations B and C shows, with a high degree of confidence, that firms that do 
more agbiotech research as measured by field tests also have a positive relationship to PVPs. 
There is also some indication that legislative changes (i.e. the 1994 PVP Amendment) had a 
positive relationship with PVPs, which was expected. Companies with multi-industry focus as 
opposed to those concentrating on agricultural biotech and seeds produce less PVPs, ceteris 
paribus. 
These results generally support our hypotheses. Biotech research as measured by field 
tests is positively related to our research output proxy, PVP applications even when total 
research is held constant. The PVP Amendment of 1994 acted to strengthen the PVP Act by 
extending protection to plant cultivars that are derived, naturally or through genetic engineering, 
from a protected variety. As this affords greater IP protection to plant cultivars, it encourages 
more productivity in creating new cultivars. This relationship is expected. The negative 
relationship between PVP applications and the large multi-industry focus of some firms suggests 
that firms which concentrate in agriculture are more efficient producers of agbiotech research 
output. This finding is evidenced by the recent decisions of a number of companies (Monsanto-
  12Pharmacia, Novartis, Zeneca, and Aventis) to split their agricultural sectors into companies that 
are separate from their pharmaceutical and other businesses.  
 
VI. Conclusion 
We undertook this project intent on documenting the impact of Biotechnological tools, 
methods, and techniques upon plant breeding programs in the U.S. This was accomplished by 
relating firm level Plant Variety Protection Certificate (PVP) application counts to corresponding 
expenditure on research and development (R&D), agbiotech patent application counts (Patents), 
field trials (Field Trials), and company structure (Focus) for an industry representative sample 
pool, and industry specific characteristics (Legislation). 
Agbiotech patent application and R&D expenditure data proved to be significantly 
correlated. The two variables are therefore interchangeable as inputs to the innovation production 
function. 
As we expected, the results demonstrated a significant and positive relationship between 
agbiotech patent applications/R&D expenditure, field trials, and the legislative Changes (i.e. the 
PVP Amendment of 1994) and the dependent variable, PVP applications. Agbiotech patents may 
be viewed as accumulated agbiotech knowledge stock which would logically lead to or spill over 
into the creation of additional Plant Varieties. R&D expenditures are a basic input to the 
innovation stream; more investment in agbiotech research activities would lead more agbiotech 
advancements. Field trials are a positive input in the agbiotech research process towards 
innovation. The PVP Act of 1994 strengthened the Act by protecting varieties created from 
varieties already under protection from 1994 on. By strengthening protection of new varieties, 
this Act made the act of creating new varieties more alluring to firms in the industry. The 
  13ramifications of the relationship between PVP applications and company focus suugests that 
firms which concentrate in agriculture are more efficient producers of agbiotech research output 
which may be part of the reason why large diversified firms are selling off their agriculture 
divisions. 
A significant and direct relationship has been illustrated between PVP applications and 
agbiotech patent applications, R&D expenditures, and field tests, all integral inputs in the 
agbiotech research process. This agbiotech research process has led to the filing of more PVP 
applications. PVP applications are by definition indicative of the creation of new plant varieties. 
Thus, we conclude that the documented agbiotech activities have had a positive effect on the 
generation of new plant varieties thereby advancing the potential for increased agricultural 
productivity. 
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